コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 istinct activation of Akt, a serine/theonine protein kinase.
2 closely related AGC-family serine/threonine protein kinases.
3 ers of the AMPK/SNF1-subfamily of basophilic protein kinases.
4 ty of different effectors, including several protein kinases.
5 ytic replication cycle through virus-encoded protein kinases.
6 been profiled on near-kinome-wide panels of protein kinases.
7 t mechanism of post-translational control of protein kinases.
8 turally related PI3 (lipid) and PI3K-related protein kinases.
10 nts in MAPK1, encoding the mitogen-activated protein kinase 1 (i.e., extracellular signal-regulated p
12 , GFAP, and phosphorylated mitogen-activated protein kinase 1 (pERK) were assessed in whole mount spe
13 the human PRKG1 gene encoding cGMP-dependent protein kinase 1 (PKG1) leads to thoracic aortic aneurys
15 RIPK1 (receptor-interacting serine/threonine-protein kinase 1), which acts as a master switch that co
17 rovide evidence that homeodomain interacting protein kinase 2 (HIPK2) and its kinase activity promote
18 nase 1 (i.e., extracellular signal-regulated protein kinase 2, ERK2), cause a neurodevelopmental dise
21 8- and receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-mediated inflammatory cell deat
22 iggers receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-mediated pathways of apoptosis
23 otic pathway, including receptor-interacting protein kinase-3 (RIPK3), mixed lineage kinase-like (MLK
25 raft mouse models revealed mitogen-activated protein kinase 7/matrix metallopeptidase 9 (MAPK7/MMP9)
26 N), zeta chain of T-cell receptor-associated protein kinase 70 (ZAP-70), and three mitogen-activated
31 (Epac 1-2)] are alternative cAMP targets to protein kinase A (PKA) and Epac2 is abundant in the cere
32 ing unbiased kinase profiling, we identified protein kinase A (PKA) as an active kinase in small cell
33 e protein phospholamban (PLN) is targeted by protein kinase A (PKA) at Ser(16) and by Ca(2+)/calmodul
34 ignaling promotes the formation of a SMAD3/4-protein kinase A (PKA) complex that activates C-terminal
36 , cyclic adenosine monophosphate (cAMP), and Protein Kinase A (PKA) exist in an oscillatory circuit c
39 LI-1, and inhibitors of adenylyl cyclase or protein kinase A (PKA) prevented the effects of Lgmn.
40 gh PAR(2) Inhibitors of adenylyl cyclase and protein kinase A (PKA) prevented the effects of Lgmn.
42 ion to mitochondria and its interaction with protein kinase A (PKA), a known node in the beta-adrener
43 odulin-dependent protein kinase II (CaMKII), protein kinase A (PKA), protein kinase C (PKC), and AMPA
44 s a multivalent binding protein that targets protein kinase A (PKA), RNAs, and other signaling enzyme
45 Synaptic SK2 levels are also regulated by protein kinase A (PKA), which phosphorylates SK2 in its
46 nses to subsequent stresses, as seen for the protein kinase A (PKA)-mediated general stress response
49 taneous measurement of cytosolic calcium and protein kinase A activity are shown, but the PIE-FLIM ap
52 -kinase anchoring proteins (AKAPs) that bind protein kinase A and other important signalling enzymes
55 This effect is not mediated by the canonical protein kinase A pathway but rather, through direct acti
57 odomains, while Zhao and coworkers find that protein kinase A regulatory subunits assemble liquid dro
62 hich via CCR1/CCR2 on cancer cells, activate protein kinase A, leading to enhanced malignant cell gly
65 m/calmodulin-dependent protein kinase II and protein kinases A and C regulate the activity of T-type
66 proteins form signaling complexes containing protein kinases A and C, which phosphorylate and activat
67 ntly of energy stress-mediated AMP-activated protein kinase activation and possibly through NADPH dep
68 enhanced collagen content and AMP-activated protein kinase activation in the scar, increased vessel
69 PI induced adenosine monophosphate-activated protein kinase activation of acetyl-coenzyme A carboxyla
70 ations of possible phosphorylation states on protein kinase activity are difficult to study experimen
71 Our findings highlight the importance of the protein kinase activity of PCK1 in the activation of SRE
72 ss-responsive activation of 5'-AMP-activated protein kinase (AMPK) and neuroprotective induction of a
74 vity of adenosine 5'-monophosphate-activated protein kinase (AMPK) in HSPC, dramatically increasing m
80 e, we investigated the role of AMP-activated protein kinase (AMPK), a master regulator of energy meta
81 deprivation-sirtuin-1 (SIRT1), AMP-activated protein kinase (AMPK), and hypoxia-inducible factors (HI
82 e (BBR), a potent activator of AMP-activated protein kinase (AMPK), can reduce beta-catenin expressio
83 nificant activation of hepatic AMP-activated protein kinase (AMPK), peroxisome proliferator-activated
84 SIRT1), forkhead box O (FoxO), AMP-activated protein kinase (AMPK), peroxisome proliferator-activated
91 e cellular energy sensor AMPK (AMP-activated protein kinase), and decreases EC proliferation without
92 being ankyrin repeat, P-loop NTPase, F-box, protein kinase, and membrane occupation and recognition
93 cei mutants that overexpress known essential protein kinases, and identified CLK1 as a primary target
94 LegK7 is structurally similar to eukaryotic protein kinases, and that MOB1A directly binds to the Le
97 ated kinase), JNK, and p38 mitogen-activated protein kinases as well as NFkappaB (nuclear factor kapp
98 We show that inhibition of CaMKII, a Ser/Thr protein kinase associated with excitability, synaptic pl
99 feration and death, but aberrantly increased protein kinase B (AKT) phosphorylation, elevated Vcan tr
100 he protein kinase B pathway by injecting the protein kinase B activator SC79 in Lgr4(-/-) mice can ef
102 etylase 8 led to the inhibition of EphA2 and protein kinase B phosphorylation, reduced invasion, and
104 PGE(2) (via protein kinase A) and FGF-2 (via protein kinase B, also known as AKT) depended on activat
105 50% (of phosphorylated IGF1R, phosphorylated protein kinase B, and phosphorylated MAPK kinase), sugge
106 thway, including key signaling intermediates protein kinase B, extracellular signal-regulated kinase
108 ate lyase (ACLY) in a TGF-beta receptor/PI3K/protein kinase B-dependent manner, to regulate hepatic a
109 ts of multisite phosphorylation on the plant protein kinase brassinosteroid insensitive 1-associated
111 l cell polarity, with expression of atypical protein kinase C (aPKC) at the contact-free domain, nucl
112 gulated by endocytic trafficking, and direct protein kinase C (PKC) activation acutely diminishes DAT
113 Activation of TRPC1-based SOCs requires protein kinase C (PKC) activity, which is proposed to ph
114 Stimulation of TRPC1-based SOCs requires protein kinase C (PKC) activity, with store-operated PKC
115 DOPr endocytosis and endosomal signaling by protein kinase C (PKC) and extracellular signal-regulate
116 ere, we demonstrate that classical and novel protein kinase C (PKC) isoforms distinctly regulate card
118 kinase II (CaMKII), protein kinase A (PKA), protein kinase C (PKC), and AMPA receptor genes that pla
121 ed proteins from public databases identified protein kinase C (PKC)zeta as a TRIM32-associated protei
123 ts of G protein-coupled serotonin receptors, protein kinase C agonists, and a microbial metabolite no
124 y reversal by histone deactylase inhibitors, protein kinase C agonists, and proteasome inhibitors wit
125 erapy identified a crucial role for enhanced protein kinase c alpha (PKCalpha) signaling and downstre
128 -CUB-domain containing protein 1 (CDCP1) and protein kinase C delta (PKCdelta)-in 56 formalin-fixed,
130 ynia induced by inflammatory injuries, while protein kinase C gamma (PKCgamma) neurons at the lamina
131 D300f receptor cytoplasmic tail inhibits the protein kinase C phosphorylation of a threonine and is a
132 zyme A reductase, phospholipase A2 receptor, protein kinase C zeta type, tubulin beta-4B class IVb, v
133 oprostanes, NOX2 (NADPH oxidase 2), and PKC (protein kinase C) were measured in obese mice and compar
134 duced phosphorylation of the kinases Lyn and protein kinase C-beta and MAPKs MKK-3/6 and p38MAPK or t
136 s via separate information pathways and that protein kinase C-dependent mechanisms regulate translati
139 e (ZIP), which was originally developed as a protein kinase C/Mzeta (PKCzeta/PKMzeta) inhibitor, is k
140 enzymatic activity of PLCdelta1, leading to protein kinase C/protein kinase D/extracellular signal-r
142 n shown in Xenopus oocytes to be affected by protein kinases C and A, we used different nonselective
143 e alpha-synuclein protein and phosphorylated protein kinase Calpha, as well as reduced abundance of l
144 ly selective oral inhibitor of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity, we
148 el, resulting in inhibition of DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) recruitment
150 at responses, whereas de novo translation in protein kinase Cdelta-expressing inhibitory neurons in t
151 (PIKKs) are large Serine/Threonine (Ser/Thr)-protein kinases central to the regulation of many fundam
152 d genes, including the conserved herpesvirus protein kinase (CHPK) that has multifunctional propertie
153 (CBL) calcium sensors and 26 CBL-Interacting Protein Kinases (CIPKs) of Arabidopsis (Arabidopsis thal
154 red that through the activities of the viral protein kinase conserved across herpesviruses and two ce
155 ith the defense-associated calcium-dependent protein kinase CPK1 and present indications this interac
156 eport that the Arabidopsis calcium-dependent protein kinase CPK3 is a key regulator of both pattern-t
158 ilization, cAMP formation, and activation of protein kinase D (PKD) and PKA, but not beta-arrestin re
159 ty of PLCdelta1, leading to protein kinase C/protein kinase D/extracellular signal-regulated kinase1/
161 ysis and ChIP-PCR together demonstrated that protein kinase D1 (Prkd1) is a direct transcriptional ta
162 ls displayed increased p38 mitogen-activated protein kinase-dependent Ripk1-independent IL-1 and tumo
163 esis of biologically important AMP-activated protein kinase deprived of any metal Pd contamination.
166 utations of PRKDC encoding the DNA-dependent protein kinase (DNA-PK) catalytic subunit (DNA-PKcs) are
173 tation in dual serine/threonine and tyrosine protein kinase (dstyk) lead to CS-like vertebral malform
175 studies demonstrate that the cGMP-dependent protein kinase EGL-4 determines the timescale of thresho
178 ase 70 (ZAP-70), and three mitogen-activated protein kinases (extracellular signal-regulated kinase,
180 l NO synthase (eNOS), cyclic GMP (cGMP), and protein kinase G (PKG) activity independently of diet, w
181 ve suggested that phosphorylation of RyR2 by protein kinase G (PKG) might contribute to the cardiopro
182 edly post-translationally enhanced by direct protein kinase G (PKG) phosphorylation at S20 (mouse, S1
184 involve at least two of the stress-activated protein kinases (GCN2 and PERK) that act on the translat
185 phosphorylated at S199 (hTau-S199-P) by the protein kinase glycogen synthase kinase 3beta (GSK3beta)
186 SPEG (striated preferentially expressed protein kinase) has been identified as the sixth gene as
188 (OGT) for Drosophila homeodomain-interacting protein kinase (Hipk)-induced growth abnormalities in re
190 t Ser(16) and by Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) at Thr(17) beta-Adrenergic st
194 In addition, calcium/calmodulin-dependent protein kinase II (CaMKII), protein kinase A (PKA), prot
195 Ca(2+) through a Ca(2+)/calmodulin-dependent protein kinase II (CaMKII)-mediated mechanism, and CaMKI
196 knowledged that calcium/calmodulin-dependent protein kinase II and protein kinases A and C regulate t
199 mRNA but not of Ca(2+)/calmodulin-dependent protein kinase IIalpha (CaMKIIalpha) mRNA in dendrites.
200 acterization of prokaryotic serine/threonine protein kinases in bacterial pathogens is emerging as an
201 informatics screen, we searched for putative protein kinases in the intracellular bacterial pathogen
202 Conversely, after dual MET/mitogen-activated protein kinase inhibition, tumor growth was significantl
203 7-trihydroxyisoflavone), a tyrosine-specific-protein kinase inhibitor, has been shown to exert an ant
204 udil, a selective Rho-associated coiled-coil protein kinase inhibitor, on corneal allograft survival.
205 acterization of the amidobenzimidazoles (AB) protein kinase inhibitors that show nanomolar potency ag
206 our multi-component explainable framework on protein kinase inhibitors, it can be extended across the
208 The ataxia-telangiectasia mutated (ATM) protein kinase is widely known for its function as a chi
209 responses by activating the c-Jun N-terminal protein kinase (JNK) and NF-kappaB pathways; however, th
210 on (STAT) (ruxolitinib) or mitogen-activated protein kinase kinase (MEK) (trametinib) and with STAT3
211 neally for 3 d or with the mitogen-activated protein kinase kinase inhibitor selumetinib by oral gava
214 ough LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of
216 e that the conserved beta-3 strand lysine of protein kinases (Lys111 of PDK1) functions as an integra
220 interfaces interfered with mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase sign
221 hway, the first described mitogen-associated protein kinase (MAPK) cascade, mediates multiple cellula
222 gens often target the host mitogen-activated protein kinase (MAPK) network to suppress host immune re
224 multiple components of the mitogen activated protein kinase (MAPK) pathway enhancing GFP(rare) expres
225 Identifying additional mitogen-activated protein kinase (MAPK) pathway regulators is invaluable i
226 iated, in part, by the p38 mitogen-activated protein kinase (MAPK) pathway responding to oxidative st
228 ions which activate p44/42 mitogen-activated protein kinase (MAPK) signaling are found in half of mye
229 dead BRAF variants amplify mitogen-activated protein kinase (MAPK) signaling by dimerizing with and a
231 tic alterations within the Mitogen Activated Protein Kinase (MAPK) signaling network that promote unp
232 entially regulated through mitogen-activated protein kinase (MAPK) signaling or genetic alteration ac
233 ranscription 3 (STAT3) and mitogen-activated protein kinase (MAPK) signaling pathways in intestinal a
234 -Jun amino-terminal kinase mitogen-activated protein kinase (MAPK) signaling to elicit a robust proin
235 Elevated Pi activates mitogen-activated protein kinase (MAPK) signaling, encompassing extracellu
238 aB activator 1 (Act1), p38 mitogen-activated protein kinase (MAPK), Jun NH2-terminal kinase (JNK), an
239 on factors are released by mitogen-activated protein kinase (MAPK)-stimulated acetylation to promote
240 threonine kinase (Akt) and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kin
241 nt allosteric inhibitor of mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kin
242 tors are phosphorylated by mitogen-activated protein kinases (MAPK) in their transactivation domains
243 apid activation of clade-A mitogen-activated protein kinases (MAPKs) MPK3 and MPK6 by wounding depend
244 n particular, we observed that AMP-activated protein kinase-mediated phosphorylation at Ser-99 promot
245 (V12) activates downstream mitogen-activated protein kinase (MEK-ERK) signaling to alter cell mechani
247 show that the deletion of the AMP-activated protein kinase ortholog-encoding gene SNF1 can restore t
248 and the involvement of p38 mitogen-activated protein kinase (p38) activated by neutrophil-derived oxi
250 containing eukaryotic-like serine/threonine protein kinases (PASTA-eSTK) that sense PG fragments.
251 nd that alterations of the mitogen-activated protein kinase pathway (KRAS and NRAS single nucleotide
253 focal adhesion kinase and mitogen-activated protein kinase pathway leading to enhanced oncogenic pro
254 ar signal-regulated kinase/mitogen-activated protein kinase) pathway integrates growth-promoting sign
255 molecular functionality of PP2A-B'gamma to a protein kinase-phosphatase interaction with the defense-
256 events in the FcepsilonRI pathway, including protein kinase phosphorylation and Ca(2+) flux, were mea
257 served phosphatidylinositol 3-kinase-related protein kinases (PIKKs) target of rapamycin (TOR) has be
258 which leads to activation of cAMP-dependent protein kinase (PKA) and subsequent cardiac protein phos
259 egulated by the activities of cAMP-dependent protein kinase (PKA) and the protein phosphatase 1 (PP1)
260 ubunits (Calpha and Cbeta) of cAMP-dependent protein kinase (PKA), a pleiotropic holoenzyme that regu
261 lic adenosine monophosphate (cAMP)-dependent protein kinase (PKA), leading to activation of the PKA p
265 2603 reveal a unique mode of regulation of a protein kinase, provide the first example of a bacterial
267 RIG-I)-dependent manner and readily activate protein kinase R (PKR), a known host double-stranded RNA
271 enesis pathway, because RLBs did not require protein kinase R, phosphorylation of eukaryotic translat
273 ly, interference with the SG process using a protein kinase R-like endoplasmic reticulum kinase inhib
274 ncluding the c-Jun N-terminal kinase and the protein kinase R-like endoplasmic reticulum kinase.
275 onses to ROS and highlight the importance of protein kinase regulation through multivalent modificati
276 show in this study that receptor-interacting protein kinase (RIPK) 3 impacts pyrin inflammasome activ
278 lls exhibited increases in mitogen-activated protein kinase signaling and cellular metabolism, as wel
282 SnRK2.8, and the ABA-independent subclass 1 protein kinases SnRK2.1, SnRK2.4, SnRK2.5, SnRK2.9, and
283 comprises the abscisic acid (ABA)-activated protein kinases SnRK2.2, SnRK2.3, SnRK2.6, SnRK2.7, and
284 es and phosphorylates a classical eukaryotic protein kinase substrate in vitro This dual Thr-Tyr kina
285 gin and evolution of redox regulation in the protein kinase superfamily and may open new avenues for
288 rated the eSimoa method for the detection of protein kinases, telomerase, histone H3 methyltransferas
291 re was also association with a transmembrane protein kinase that may function as a receptor for the e
292 igin activation is under control of multiple protein kinases that either promote or inhibit origin ac
295 ibe the profiling of a non-receptor tyrosine-protein kinase (TYK2) inhibitor which shows a functional
298 species and activation of mitogen-activated protein kinases upon exposure to flg22 and flgII-28.
301 stimulates phosphorylation of AMP-activated protein kinase, which leads to phosphorylation of the ma